NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient

Printer-friendly versionPrinter-friendly version
Sevastianova K, Dean J, Bannan C, Coghlan M, Farrell G, Murray C, De Gascun CF, Bergin C
J Clin Virol. 2016 Sep;82:66-69